Home > National Drug Code (NDC) > Anew Clinical

Anew Clinical - 10096-0290-2 - (OCTINOXATE, OXYBENZONE, AVOBENZONE)

Alphabetical Index


Drug Information of Anew Clinical

Product NDC: 10096-0290
Proprietary Name: Anew Clinical
Non Proprietary Name: OCTINOXATE, OXYBENZONE, AVOBENZONE
Active Ingredient(s): 20; 75; 40    mg/g; mg/g; mg/g & nbsp;   OCTINOXATE, OXYBENZONE, AVOBENZONE
Administration Route(s): TOPICAL
Dosage Form(s): CREAM
Coding System: National Drug Codes(NDC)

Labeler Information of Anew Clinical

Product NDC: 10096-0290
Labeler Name: Avon Products, Inc
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20121111

Package Information of Anew Clinical

Package NDC: 10096-0290-2
Package Description: 1 TUBE in 1 CARTON (10096-0290-2) > 75 g in 1 TUBE (10096-0290-1)

NDC Information of Anew Clinical

NDC Code 10096-0290-2
Proprietary Name Anew Clinical
Package Description 1 TUBE in 1 CARTON (10096-0290-2) > 75 g in 1 TUBE (10096-0290-1)
Product NDC 10096-0290
Product Type Name HUMAN OTC DRUG
Non Proprietary Name OCTINOXATE, OXYBENZONE, AVOBENZONE
Dosage Form Name CREAM
Route Name TOPICAL
Start Marketing Date 20121111
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Avon Products, Inc
Substance Name AVOBENZONE; OCTINOXATE; OXYBENZONE
Strength Number 20; 75; 40
Strength Unit mg/g; mg/g; mg/g
Pharmaceutical Classes

Complete Information of Anew Clinical


General Information